Viewing Study NCT00160251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:46 PM
Ignite Modification Date: 2026-07-08 @ 3:16 PM
Study NCT ID: NCT00160251
Status: COMPLETED
Last Update Posted: 2015-10-14
First Post: 2005-09-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PEG-Intron View
None Ribavirin View
None Protease Inhibitor View